Kerry K. Reinertsen
Corporate Officer/Principal at REGENERON PHARMACEUTICALS, INC.
Profile
Kerry K.
Reinertsen is a professional who currently works as Senior Vice President-Strategic Alliances at Regeneron Pharmaceuticals, Inc. She has previously worked as Vice President-Corporate & Business Development at Vertex Pharmaceuticals, Inc. from 2004 to 2009 and as Chief Business Officer at Constellation Pharmaceuticals, Inc. from 2010 to 2011.
She has also worked as a Principal at Millennium Pharmaceuticals, Inc. Dr. Reinertsen has an undergraduate degree from Brown University and a doctorate from Harvard University.
Kerry K. Reinertsen active positions
| Companies | Position | Start |
|---|---|---|
| REGENERON PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/01/2011 |
Former positions of Kerry K. Reinertsen
| Companies | Position | End |
|---|---|---|
| CONSTELLATION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/01/2011 |
| VERTEX PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | 01/01/2009 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Training of Kerry K. Reinertsen
| Brown University | Undergraduate Degree |
| Harvard University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
| REGENERON PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Constellation Pharmaceuticals, Inc.
 Constellation Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Constellation Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics in the field of epigenetics. The firm utilizes epigenetics platform, which enables to validate targets and generate small molecules against these targets that selectively modulate gene expression in tumor and immune cells to drive anti-tumor activity. Its product include CPI-0610, CPI-1205, and CPI-0209. The company was founded by Danny Reinberg, David Allis, and Yang Shi on January 11, 2008 and is headquartered in Cambridge, MA. | Health Technology |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Kerry K. Reinertsen
